MX2010004916A - Proceso para predecir el pronostico de cancer en celulas escamosas de pulmon. - Google Patents

Proceso para predecir el pronostico de cancer en celulas escamosas de pulmon.

Info

Publication number
MX2010004916A
MX2010004916A MX2010004916A MX2010004916A MX2010004916A MX 2010004916 A MX2010004916 A MX 2010004916A MX 2010004916 A MX2010004916 A MX 2010004916A MX 2010004916 A MX2010004916 A MX 2010004916A MX 2010004916 A MX2010004916 A MX 2010004916A
Authority
MX
Mexico
Prior art keywords
mir
hsa
prognosis
predicting
lung cancer
Prior art date
Application number
MX2010004916A
Other languages
English (en)
Inventor
Mitch Raponi
Lesley Estelle Dossey
Original Assignee
Veridex Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veridex Llc filed Critical Veridex Llc
Publication of MX2010004916A publication Critical patent/MX2010004916A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Abstract

La especificación describe un método para predecir el pronóstico de cáncer en células escamosas de pulmón al observar cambios regulatorios en secuencias miARN seleccionadas. Estas secuencias pueden incluir hsa-mir-146b, hsa-mir-191, hsa-mir-206, hsa-mir-299-3p, hsa-mir-155, hsa-mir-15a, hsa-mir-122a, hsa-mir-513, hsa-mir-184, hsa-mir-511, hsa-mir-100, hsa-mir-10a, hsa-mir-453, hsa-mir-379, hsa-mir-202, hsa-mir-21, hsa-mir-126, hsa-mir-494, hsa-mir-432, hsa-mir-370, y combinaciones de éstas.
MX2010004916A 2007-10-30 2008-10-30 Proceso para predecir el pronostico de cancer en celulas escamosas de pulmon. MX2010004916A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98375607P 2007-10-30 2007-10-30
PCT/US2008/081809 WO2009059016A1 (en) 2007-10-30 2008-10-30 Process for predicting the prognosis of squamous cell lung cancer

Publications (1)

Publication Number Publication Date
MX2010004916A true MX2010004916A (es) 2010-05-20

Family

ID=40202867

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004916A MX2010004916A (es) 2007-10-30 2008-10-30 Proceso para predecir el pronostico de cancer en celulas escamosas de pulmon.

Country Status (10)

Country Link
US (2) US7927805B2 (es)
EP (1) EP2215263A1 (es)
JP (1) JP2011501964A (es)
KR (1) KR20100093538A (es)
CN (1) CN101878313A (es)
BR (1) BRPI0818478A2 (es)
CA (1) CA2704062A1 (es)
IL (1) IL205347A0 (es)
MX (1) MX2010004916A (es)
WO (1) WO2009059016A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100111726A (ko) 2008-02-01 2010-10-15 아메리곤 인코포레이티드 열전 소자용 응결 센서 및 습도 센서
US7998677B2 (en) * 2008-02-26 2011-08-16 Regulus Therapeutics, Inc. MicroRNA detection
WO2009133915A1 (ja) * 2008-04-30 2009-11-05 日本電気株式会社 癌マーカー、それを用いた癌の評価方法および評価試薬
US8790916B2 (en) 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid
CN101991852B (zh) * 2010-11-05 2012-10-17 中国人民解放军第四军医大学 miR-494抑制剂在制备抗骨钙丢失、促骨生成制剂中的应用
ES2632145T3 (es) * 2010-12-01 2017-09-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Modo de predicción del desenlace de un cáncer analizando la expresión de miARN
CN102851283B (zh) * 2011-06-30 2014-07-30 上海市肿瘤研究所 用于区分转移与非转移肺鳞癌的microRNA标志物
US9685599B2 (en) 2011-10-07 2017-06-20 Gentherm Incorporated Method and system for controlling an operation of a thermoelectric device
US9989267B2 (en) 2012-02-10 2018-06-05 Gentherm Incorporated Moisture abatement in heating operation of climate controlled systems
CN102743765A (zh) * 2012-05-24 2012-10-24 上海大学 非小细胞肺癌中miR-10a基因的应用
US9662962B2 (en) 2013-11-05 2017-05-30 Gentherm Incorporated Vehicle headliner assembly for zonal comfort
WO2018046738A1 (en) * 2016-09-12 2018-03-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the survival time of patients suffering from cancer
CN116367723A (zh) 2020-10-05 2023-06-30 T3生物科学有限责任公司 用于防治植物病害的假单胞菌属菌株及其代谢物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4120002B2 (ja) 2004-01-07 2008-07-16 愛知県 ｍｉＲＮＡを用いた癌の予後判定方法、癌の遺伝子治療ベクター及び癌治療用医薬組成物
EP1784501B1 (en) 2004-05-14 2015-11-18 Rosetta Genomics Ltd VIRAL AND VIRUS ASSOCIATED MicroRNAS AND USES THEREOF
WO2007081720A2 (en) * 2006-01-05 2007-07-19 The Ohio State University Research Foundation Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
CA2633754C (en) * 2006-01-05 2013-06-18 The Ohio State University Research Foundation Microrna-based methods and compositions for the diagnosis and treatment of solid cancers
US7955848B2 (en) * 2006-04-03 2011-06-07 Trustees Of Dartmouth College MicroRNA biomarkers for human breast and lung cancer
US20080076674A1 (en) * 2006-07-06 2008-03-27 Thomas Litman Novel oligonucleotide compositions and probe sequences useful for detection and analysis of non coding RNAs associated with cancer
CN101918424A (zh) * 2007-06-15 2010-12-15 俄亥俄州立大学研究基金会 用于靶向由Drosha介导的微小RNA加工的致癌ALL-1融合蛋白
CA2702241A1 (en) * 2007-10-11 2009-04-16 The Ohio State University Research Foundation Methods and compositions for the diagnosis and treatment of esophageal adenocarcinomas

Also Published As

Publication number Publication date
EP2215263A1 (en) 2010-08-11
US20090136949A1 (en) 2009-05-28
KR20100093538A (ko) 2010-08-25
JP2011501964A (ja) 2011-01-20
CA2704062A1 (en) 2009-05-07
US7927805B2 (en) 2011-04-19
BRPI0818478A2 (pt) 2015-04-14
IL205347A0 (en) 2010-12-30
US20110171657A1 (en) 2011-07-14
WO2009059016A1 (en) 2009-05-07
CN101878313A (zh) 2010-11-03

Similar Documents

Publication Publication Date Title
MX2010004916A (es) Proceso para predecir el pronostico de cancer en celulas escamosas de pulmon.
US20220042102A1 (en) Mirna fingerprint in the diagnosis of lung cancer
MX2010004917A (es) Proceso para monitorear el cancer colorrectal.
CN101921760B (zh) 一种与乳腺癌相关的血清/血浆miRNA标志物及其应用
Ali et al. Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer
Corté et al. MicroRNA and colorectal cancer
Wu et al. Potentially predictive microRNAs of gastric cancer with metastasis to lymph node
AU2017225061B2 (en) Biomarkers and methods of treating PD-1 and PD-L1 related conditions
US20150292020A1 (en) miRNA Fingerprint in the Diagnosis of COPD
Leite et al. MicroRNA expression profiles in the progression of prostate cancer—from high-grade prostate intraepithelial neoplasia to metastasis
Pan et al. MicroRNA dysregulation in gastric cancer
CO6231056A2 (es) Prediccion de la supervivencia al pos-tratamiento en pacientes de cancer con micro-rnas
Qin et al. Deep-sequencing analysis reveals that the miR-199a2/214 cluster within DNM3os represents the vast majority of aberrantly expressed microRNAs in Sezary syndrome
NZ608153A (en) Epigenetic markers of colorectal cancers and diagnostic methods using the same
UA110790C2 (uk) Спосіб передбачування рецидиву раку молочної залози при ендокринному лікуванні
WO2008055158A3 (en) Microrna as biomarker in cancer
WO2012154567A3 (en) Human invasion signature for prognosis of metastatic risk
EA202190474A1 (ru) Терапия на основе микро-рнк, направленная против lcp-1-позитивных раковых опухолей
EP2596136A4 (en) PLASMA MICROARN MARKER AND NEW DIAGNOSTIC METHOD FOR HEPATOCELLULAR CARCINOMA
EA201290107A1 (ru) Способ определения пациента как восприимчивого или не восприимчивого к иммунотерапии
WO2011021177A3 (en) Compositions and methods for prognosis and treatment of prostate cancer
EP3862441A2 (en) Method for the early diagnosis of cancer by means of ddpcr analysis of mirna and protein markers in liquid biopsy
EP3444362A3 (en) Circulating mirnas as early detection marker and prognostic marker
Lajer et al. The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer
WO2009086000A3 (en) Biomarkers for trichogenicity